000 01481 a2200433 4500
005 20250518005823.0
264 0 _c20190911
008 201909s 0 0 eng d
022 _a1744-8042
024 7 _a10.2217/pgs-2018-0099
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChang, Donald D
245 0 0 _aPharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
_h[electronic resource]
260 _bPharmacogenomics
_c11 2018
300 _a1269-1284 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aDepression
_xdrug therapy
650 0 4 _aDepressive Disorder, Major
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
_xstandards
650 0 4 _aPharmacogenomic Testing
_xstandards
650 0 4 _aPrecision Medicine
_xstandards
700 1 _aEyreeuro, Harris A
700 1 _aAbbott, Ryan
700 1 _aCoudreaut, Michael
700 1 _aBaune, Bernhard T
700 1 _aShaman, Jeffrey A
700 1 _aLavretsky, Helen
700 1 _aLenze, Eric J
700 1 _aMerrill, David A
700 1 _aSingh, Ajeet B
700 1 _aMulsant, Benoit H
700 1 _aReynolds, Charles F
700 1 _aMüller, Daniel J
700 1 _aBousman, Chad
773 0 _tPharmacogenomics
_gvol. 19
_gno. 16
_gp. 1269-1284
856 4 0 _uhttps://doi.org/10.2217/pgs-2018-0099
_zAvailable from publisher's website
999 _c29037680
_d29037680